Figure 5 shows the significant differential expression between the tumor and paired-normal tissues. Specifically, VCAM1 (p = 7.9 × 10−7), DBI (p = 1.1 × 10−6), ACAA1 (p = 7.0 × 10−12), GIMAP7 (p = 2.0 × 10−11), CD72 (p = 0.021), B4GAT1 (p = 1.1 × 10−11), TMEM132C (p = 2.0 × 10−10), HYAL1 (p = 3.1 × 10−4), NCR1 (p = 1.5 × 10−6), and SPARCL1 (p = 1.7 × 10−10)were significantly overexpressed in tumor tissue, whereas SERPINH1 (p = 1.3 × 10−5) and LRP11 (p = 4.9 × 10−3)were significantly downregulated. This evidence concerns the gene SPARCL1 and neoplasm.